Notice: amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `pre_get_posts` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the theme with slug `publisher` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/runcloud/webapps/techilive/wp-includes/functions.php on line 5313
Delhi govt sets up panel for timely distribution of Amphotericin-B injection to hospitals - ET HealthWorld -

Delhi govt sets up panel for timely distribution of Amphotericin-B injection to hospitals – ET HealthWorld


The Delhi government has set up a four-member technical expert committee (TEC) to prevent the indiscriminate use of Amphotericin-B injection and to establish a transparent and efficient system of distribution of this drug to the needy and hospitalised Covid-19 patients.

The drug is used in the treatment of black fungus or mucormycosis and is currently in short supply.

Hospitals in Delhi have reported a rise in the number of black fungus cases among people recovering from Covid-19 during the second wave and it could be ascribed to “irrational” use of steroids at home without consulting a doctor.


The expert committee will be headed by Pulmonologist Dr M K Daga, and include Dr Manisha Aggarwal, Dr S Anuradha and Dr Ravi Mehar from Maulana Azad Medical College.

All Covid hospitals requiring Amphotericin-B for treatment of patients will have to apply to the experts committee which will meet twice a day to scrutinise these applications and facilitate rapid decision making “as time is of the essence in such cases”, according to an order issued by the health department.

“The guiding principles for TEC shall be evidence-based clinically approved parameters as well as principles of equity, distributive justice and transparency,” the order read.


The Directorate General of Health Services should coordinate with the TEC and facilitate rapid decision making and also monitor the overall management of the drug from approval till delivery to the hospital concerned, it said.

The decision of daily meetings will be conveyed to all the stakeholders through e-mail and reasons for refusal will be written and informed to the requisitioning hospitals.


Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Health News Click Here 


 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – The content will be deleted within 24 hours.

Leave a comment